Mortality despite new generation medications for pediatric neuromuscular diseases and how to prevent it
World Journal of Translational Medicine · 2026
DOI: 10.5528/wjtm.121646 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Translational Medicine, 2026. Verfasst von Maninderpal Kaur und 1 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
With severe respiratory muscle weakness of pediatric patients with progressive neuromuscular disorders, progressive hypercapnic ventilatory failure can result in cor pulmonale but, even more often, otherwise benign upper respiratory tract infections result in pneumonia, supplemental oxygen administration, hypercapnic respiratory failure, coma, intubation, failure to ventilator wean, then the options of tracheotomy or terminal extubation with O2 and morphine. While new medications for spinal muscular atrophy, Pompe disease, and Duchenne muscular dystrophy can slow deterioration, cough peak flows can become or remain ineffective to clear the airways to prevent those two options. This work reviewed publications that demonstrate that instead of weaning from ventilatory support to be extubated, it can be only by extubating or decannulating ventilator unweanable patients that permit them to wean back to any ventilator use regimens they used before hospitalization. Avoiding tracheostomies for mechanical ventilation can also result in over half a million dollars per year in cost savings as well as preserve quality of life.
Zitieren
APA
Kaur, M., & Bach, J. R. (2026). Mortality despite new generation medications for pediatric neuromuscular diseases and how to prevent it. World Journal of Translational Medicine. https://doi.org/10.5528/wjtm.121646
Vancouver
Kaur M, Bach JR. Mortality despite new generation medications for pediatric neuromuscular diseases and how to prevent it. World Journal of Translational Medicine. 2026. doi:10.5528/wjtm.121646
BibTeX
@article{Kaur2026,
author = {Kaur, Maninderpal and Bach, John R},
title = {Mortality despite new generation medications for pediatric neuromuscular diseases and how to prevent it},
journal = {World Journal of Translational Medicine},
year = {2026},
doi = {10.5528/wjtm.121646}
}
EUVIMED